
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis
Christina Lückel, Felix S.R. Picard, Hartmann Raifer, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 84
Christina Lückel, Felix S.R. Picard, Hartmann Raifer, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 84
Showing 1-25 of 84 citing articles:
Lactate modulation of immune responses in inflammatory versus tumour microenvironments
Michelangelo Certo, Chin‐Hsien Tsai, Valentina Pucino, et al.
Nature reviews. Immunology (2020) Vol. 21, Iss. 3, pp. 151-161
Closed Access | Times Cited: 555
Michelangelo Certo, Chin‐Hsien Tsai, Valentina Pucino, et al.
Nature reviews. Immunology (2020) Vol. 21, Iss. 3, pp. 151-161
Closed Access | Times Cited: 555
Targeting immunometabolism as an anti-inflammatory strategy
Eva M. Pålsson‐McDermott, Luke O'neill
Cell Research (2020) Vol. 30, Iss. 4, pp. 300-314
Open Access | Times Cited: 394
Eva M. Pålsson‐McDermott, Luke O'neill
Cell Research (2020) Vol. 30, Iss. 4, pp. 300-314
Open Access | Times Cited: 394
The impact of the gut microbiome on extra-intestinal autoimmune diseases
Eiji Miyauchi, Chikako Shimokawa, Alex Steimle, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 1, pp. 9-23
Closed Access | Times Cited: 232
Eiji Miyauchi, Chikako Shimokawa, Alex Steimle, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 1, pp. 9-23
Closed Access | Times Cited: 232
Metabolic adaptation of lymphocytes in immunity and disease
Nicole M. Chapman, Hongbo Chi
Immunity (2022) Vol. 55, Iss. 1, pp. 14-30
Open Access | Times Cited: 187
Nicole M. Chapman, Hongbo Chi
Immunity (2022) Vol. 55, Iss. 1, pp. 14-30
Open Access | Times Cited: 187
Interleukin-17 in Chronic Inflammatory Neurological Diseases
Jelena Milovanović, Aleksandar Arsenijević, Bojana Stojanović, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 169
Jelena Milovanović, Aleksandar Arsenijević, Bojana Stojanović, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 169
CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential
Choong‐Hyun Koh, Suyoung Lee, Minkyeong Kwak, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 11, pp. 2287-2299
Open Access | Times Cited: 107
Choong‐Hyun Koh, Suyoung Lee, Minkyeong Kwak, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 11, pp. 2287-2299
Open Access | Times Cited: 107
Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8+ T cells in the tumor microenvironment
Jie Cheng, Jinxin Yan, Ying Liu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 6, pp. 961-978.e10
Open Access | Times Cited: 77
Jie Cheng, Jinxin Yan, Ying Liu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 6, pp. 961-978.e10
Open Access | Times Cited: 77
IL-17A-producing CD8+T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts
Felix S.R. Picard, Veronika Lutz, Anna Brichkina, et al.
Gut (2023) Vol. 72, Iss. 8, pp. 1510-1522
Open Access | Times Cited: 48
Felix S.R. Picard, Veronika Lutz, Anna Brichkina, et al.
Gut (2023) Vol. 72, Iss. 8, pp. 1510-1522
Open Access | Times Cited: 48
Regulation of immunomodulatory networks by Nrf2-activation in immune cells: Redox control and therapeutic potential in inflammatory diseases
Tarun Pant, Nnamdi Uche, Matea Juric, et al.
Redox Biology (2024) Vol. 70, pp. 103077-103077
Open Access | Times Cited: 27
Tarun Pant, Nnamdi Uche, Matea Juric, et al.
Redox Biology (2024) Vol. 70, pp. 103077-103077
Open Access | Times Cited: 27
Relevance of Essential Trace Elements in Nutrition and Drinking Water for Human Health and Autoimmune Disease Risk
Daniela Cannas, Eleonora Loi, Matteo Serra, et al.
Nutrients (2020) Vol. 12, Iss. 7, pp. 2074-2074
Open Access | Times Cited: 117
Daniela Cannas, Eleonora Loi, Matteo Serra, et al.
Nutrients (2020) Vol. 12, Iss. 7, pp. 2074-2074
Open Access | Times Cited: 117
Inflammation in multiple sclerosis
Stefanie Haase, Ralf A. Linker
Therapeutic Advances in Neurological Disorders (2021) Vol. 14
Open Access | Times Cited: 95
Stefanie Haase, Ralf A. Linker
Therapeutic Advances in Neurological Disorders (2021) Vol. 14
Open Access | Times Cited: 95
Prodrugs for Improved Drug Delivery: Lessons Learned from Recently Developed and Marketed Products
Milica Marković, Shimon Ben‐Shabat, Arik Dahan
Pharmaceutics (2020) Vol. 12, Iss. 11, pp. 1031-1031
Open Access | Times Cited: 93
Milica Marković, Shimon Ben‐Shabat, Arik Dahan
Pharmaceutics (2020) Vol. 12, Iss. 11, pp. 1031-1031
Open Access | Times Cited: 93
Current and emerging disease‐modulatory therapies and treatment targets for multiple sclerosis
Fredrik Piehl
Journal of Internal Medicine (2020) Vol. 289, Iss. 6, pp. 771-791
Open Access | Times Cited: 78
Fredrik Piehl
Journal of Internal Medicine (2020) Vol. 289, Iss. 6, pp. 771-791
Open Access | Times Cited: 78
Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis
Pengfei Wang, Fei Jiang, Qiuming Zeng, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Pengfei Wang, Fei Jiang, Qiuming Zeng, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 11
COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis
Vittorio Mantero, Lucia Abate, Paola Basilico, et al.
Journal of Neurology (2020) Vol. 268, Iss. 6, pp. 2023-2025
Open Access | Times Cited: 61
Vittorio Mantero, Lucia Abate, Paola Basilico, et al.
Journal of Neurology (2020) Vol. 268, Iss. 6, pp. 2023-2025
Open Access | Times Cited: 61
Candida albicans and candidalysin in inflammatory disorders and cancer
Jemima Ho, Giorgio Camilli, James S. Griffiths, et al.
Immunology (2020) Vol. 162, Iss. 1, pp. 11-16
Open Access | Times Cited: 55
Jemima Ho, Giorgio Camilli, James S. Griffiths, et al.
Immunology (2020) Vol. 162, Iss. 1, pp. 11-16
Open Access | Times Cited: 55
Tc17 biology and function: Novel concepts
Christina Lückel, Felix S.R. Picard, Magdalena Huber
European Journal of Immunology (2020) Vol. 50, Iss. 9, pp. 1257-1267
Open Access | Times Cited: 52
Christina Lückel, Felix S.R. Picard, Magdalena Huber
European Journal of Immunology (2020) Vol. 50, Iss. 9, pp. 1257-1267
Open Access | Times Cited: 52
The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis
Caterina Veroni, Francesca Aloisi
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 52
Caterina Veroni, Francesca Aloisi
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 52
Hub genes, a diagnostic model, and immune infiltration based on ferroptosis-linked genes in schizophrenia
Kun Lian, Yongmei Li, Wei Yang, et al.
IBRO Neuroscience Reports (2024) Vol. 16, pp. 317-328
Open Access | Times Cited: 6
Kun Lian, Yongmei Li, Wei Yang, et al.
IBRO Neuroscience Reports (2024) Vol. 16, pp. 317-328
Open Access | Times Cited: 6
Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis
Wendy Gilmore, Brett T. Lund, Peili Li, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 46
Wendy Gilmore, Brett T. Lund, Peili Li, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 46
FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models
R. Rajendran, Gregor Böttiger, Christine Stadelmann, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 884-884
Open Access | Times Cited: 40
R. Rajendran, Gregor Böttiger, Christine Stadelmann, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 884-884
Open Access | Times Cited: 40
Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis
Klara Asplund Högelin, Nicolas Ruffin, Elisa Pin, et al.
iScience (2021) Vol. 24, Iss. 9, pp. 103078-103078
Open Access | Times Cited: 39
Klara Asplund Högelin, Nicolas Ruffin, Elisa Pin, et al.
iScience (2021) Vol. 24, Iss. 9, pp. 103078-103078
Open Access | Times Cited: 39
High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature
Anna-Maria Globig, A Hipp, Patricia Otto-Mora, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Anna-Maria Globig, A Hipp, Patricia Otto-Mora, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
CD8+ T Cell-Mediated Mechanisms Contribute to the Progression of Neurocognitive Impairment in Both Multiple Sclerosis and Alzheimer's Disease?
Zorica Stojić-Vukanić, Senka Hadžibegović, Olivier Nicole, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 37
Zorica Stojić-Vukanić, Senka Hadžibegović, Olivier Nicole, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 37
Dimethyl fumarate treatment shifts the immune environment toward an anti-inflammatory cell profile while maintaining protective humoral immunity
Erin E. Longbrake, Yang Mao‐Draayer, Mark Cascione, et al.
Multiple Sclerosis Journal (2020) Vol. 27, Iss. 6, pp. 883-894
Open Access | Times Cited: 35
Erin E. Longbrake, Yang Mao‐Draayer, Mark Cascione, et al.
Multiple Sclerosis Journal (2020) Vol. 27, Iss. 6, pp. 883-894
Open Access | Times Cited: 35